Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-02-10

Clinical Trial Update: Bimatoprost in the Treatment of Eyelash Hypotrichosis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating bimatoprost for idiopathic eyelash hypotrichosis completed, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bimatoprost (bimatoprost)

Snippet

Sponsor: Allergan | Conditions: Idiopathic Eyelash Hypotrichosis | Phase 3 | Status: COMPLETED | Results posted: 2015-02-10